Springer Medicine

This account is verified because it's an official organization on X. Learn more

@Springer_Med

Trustworthy, tailored, cutting-edge content for medical professionals who want to deliver the best possible care. #EdsChoice selections by the content team.

springermedicine.com Joined March 2023

241 Following 8.8K Followers 2.1K Posts

Latest posts 5

Pinned post

Springer Medicine @Springer_Med Oct 29

Catch up on the latest breakthroughs and top stories from #ESMO2026 with our congress hub.

Stay tuned for expert insights and highlights from across the spectrum of oncology.

👉️ buff.ly/etVU0ex

Springer Medicine @Springer_Med 15h

From #UEGWeek2026 - Prof. Axel Dignass outlines the latest recommendations published in the STRIDE-III #IBD treatment target guidance.

Watch the full interview 👉️ buff.ly/A6V9TMH

#GITwitter

0:26

Springer Medicine @Springer_Med 1d

From #ESMO2026 - Dr. James Harding shares a few key hepatobiliary cancer studies before taking a deep dive into the HARMONi-GI1 trial of first-line ivonescimab plus chemotherapy in advanced biliary tract cancer.

Watch the full interview 👉️ buff.ly/nYrunyn

0:42

Springer Medicine @Springer_Med 2d

From #ESMO2026 - The HER2-targeted bispecific antibody anbenitamab plus albumin-bound docetaxel shows potential for the first-line treatment of HER2-positive advanced #BreastCancer.

Full story 👉️ buff.ly/Owwsns0

#MedNews

www.springermedicine.com PFS boost with anbenitamab plus HB1801 in HER2-positive advanced breast cancer From ESMO 2026: The HER2-targeted bispecific antibody anbenitamab plus albumin-bound docetaxel shows potential for the first-line treatment of

Springer Medicine @Springer_Med 2d

From #UEGWeek2026 - Dr. Carlo Senore discusses the latest screening recommendations from the European Commission Initiative on Colorectal Cancer, outlining the key eligibility criteria and modalities.

Watch the full video 👉️ buff.ly/L6zfyPC

#GITwitter

0:41